RE:NewsI agree about PR outlays but also have to add while I don't see what their motives are, perhaps they 'see' meaningful progress is in their sights. As to padding their own pockets with the options, well, since we can all buy shares around 21c and padding pockets means the sp has to increase, well, we all have that op, except of course they do not put capital in upfront.
Progress has been painstakingly slow but there has been progress on Diabates-1 front and I guess that this focus meant the Euro 225k they got in 2017 for the haemophilia side of things has simply got lost somewhere. Slow progress is the name of the game especially for this novel pouch idea and all that it entails. Still Diabetes-1 and Haemophilia are darn big markets and that, IMO, is the reason to remain invested in SVA.